Company Directory / research

PrivateFor profitresearchSeattle, United States
Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics.
Size
11-50 people: larger than 33% of companies with a size listed
Age
8 years old.
Reach
Website ranked #2,783,369 in the world for traffic, about 6k visits a month.
BiotechnologyGeneticsMedicalTherapeutics
Funding, as listed
$130M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Variant Bio, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
Variant Bio may be growing as evidenced by its partnership with Evotec to develop fibrosis treatments. This collaboration indicates an expansion of Variant Bio's research and development capabilities, which is a positive indicator of growth in the biotechnology and therapeutics industry. The partnership with a notable company like Evotec suggests that Variant Bio is increasing its operational scope and potentially its market presence, which are both indicative of a company in a growth phase.
Summaries written by the source dataset, not by us, and not checked.
research in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.